JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alfredo Trento
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trento, A.
Right arrow Articles by Czer, L. S.C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Trento, A.
Right arrow Articles by Czer, L. S.C.
Related Collections
Right arrow Coronary disease
Right arrow Valve disease

J Thorac Cardiovasc Surg 2009;138:286-288
© 2009 The American Association for Thoracic Surgery


Point/Counterpoint

COUNTERPOINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation

Alfredo Trento, MD*, Sorel Goland, MD, Michele A. De Robertis, RN, Lawrence S.C. Czer, MD

Division of Cardiothoracic Surgery and Cardiology, Cedars–Sinai Medical Center, Los Angeles, Calif

Received for publication May 23, 2008; revisions received April 6, 2009; accepted for publication May 2, 2009.

* Address for reprints: Alfredo Trento, MD, Cedars–Sinai Medical Center, Cardio-Thoracic Surgery, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048. (Email: alfredo.trento@cshs.org).

The first 300 words of the full text of this article appear below.


    Introduction
 
Dr Fattouch and colleagues present the first prospective randomized trial on the very controversial group of patients with chronic moderate ischemic mitral regurgitation (MR) undergoing coronary artery bypass (CAB). They randomized 100 patients with 2+ ischemic MR to CAB alone and combined CAB plus restrictive mitral annuloplasty. All patients had a prior myocardial infarction (MI) and decreased ventricular function (ejection fraction [EF], 42%), New York Heart Association (NYHA) class was 2.3, left ventricular end-diastolic diameter (LVEDD) was 59 mm, and pulmonary artery pressure was 40 mm Hg. The 5-year survival was 88.8% in the CAB-only group and 93.7% in the combined group. The combined group showed reverse remodeling with resolution of MR at 5 years (mean MR grade, 0.08 ± 0.2; LVEDD, 52 mm; left ventricular [LV] EF, 48%; pulmonary artery pressure, 26 mm Hg; and mean NYHA class, 0.6). The CAB-only group showed an insignificant improvement in functional parameters and worsening of MR in 35%. Exercise echocardiographic analysis was basically normal in the combined group but significantly impaired in the CAB-only group. These results are impressive.


    Retrospective Studies
 
Previous publications have been retrospective studies that have important limitations even when statistical analysis of propensity-matched groups was used to compensate for the bias related to patient selection (Table 1 ).1-6Go One such study was published in the past year by the Cleveland Clinic group.1Go Mihaljevic and colleagues1Go reviewed 390 patients from 1991 to 2003 with 3+ or 4+ ischemic MR. Of these, 290 underwent CAB plus mitral valve (MV) annuloplasty, and 100 underwent CAB alone. Groups were propensity matched by using demographics, extent of coronary artery disease, regional wall motion, and quantitative echocardiographic analysis. The 1-, 5-, and 10-year survivals were 88%, 75%, and 47% after CAB alone and 92%, 74%, and 39% after CAB plus mitral annuloplasty. NYHA class improved . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Kainuma, K. Taniguchi, K. Toda, T. Funatsu, H. Kondoh, M. Nishino, T. Daimon, and Y. Sawa
Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation
J. Thorac. Cardiovasc. Surg., October 1, 2011; 142(4): 783 - 792.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. J. Gardner and P. T. O'Gara
The Cardiothoracic Surgery Network: Randomized clinical trials in the operating room.
J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 830 - 834.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.